You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery

    SBC: MERCATOR MEDSYSTEMS, INC.            Topic: NHLBI

    PROJECT SUMMARY Post-thrombotic syndrome (PTS) is a chronic debilitating condition characterized by limb swelling and discomfort, hyperpigmentation, skin ulcers, and impaired quality of life. It occurs within 2 years of deep vein thrombosis (DVT) treatment in 50-60% of patients with iliofemoral thrombosis and in 30-50% of all DVT patients regardless of thrombosis location (1). Even with pharmacolo ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  2. A novel approach to Mesenchymal Stem Cell Transduction

    SBC: OSSIUM HEALTH INC            Topic: NHLBI

    PROJECT SUMMARY Mesenchymal stem cells (MSC) are in clinical development for cardiovascular, neurologic, orthopedic, and other indications. Ossium is developing a novel source of MSC from vertebral bodies (vbMSC). Genetic modification of vbMSC using lentiviral vector (LV) has the potential to improve the therapeutic potential. Understanding how genetic modification might alter the vbMSC phenotype ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  3. Cockpit Electromagnetic Radiation Testing And INterpretation (CERTAIN): Phase II

    SBC: TRIPLE RING TECHNOLOGIES INC            Topic: HR001120S001918

    The concern identified in the DARPA Impact of Cockpit Electro-Magnetics on Aircrew Neurology (ICEMAN) STTR Opportunity Announcement is that strong electromagnetic fields (EMF) within modern Department of Defense (DoD) aircraft cockpits may be degrading pilot performance and potentially leading to mishaps including loss of life.  Proposers received funding for a Phase 1 effort responding to the an ...

    STTR Phase II 2021 Department of DefenseDefense Advanced Research Projects Agency
  4. Effects of RF and Geomagnetic Fields on pilot performance, implicit behavior, sensory perception, and cognition

    SBC: APPLIED PHYSICS SYSTEMS, INC.            Topic: HR001120S001918

    It is unknown how cockpit EM and RF exposures might affect pilot performance and physiology.  Animal, human, and physics research indicate that a pathway for such exposures to impact human physiology exists via aggregations of magnetite, a ferromagnetic nanocrystal.  Aggregations of magnetite have been found in many animal tissues, including in the human brain; they have been linked to magnetore ...

    STTR Phase II 2021 Department of DefenseDefense Advanced Research Projects Agency
  5. Human Performance Enhancement

    SBC: REJUVENATE BIO INC            Topic: SOCOM17C001

    Special Operations Forces (SOF) operators are among the most elite, and highly qualified individuals in the U.S. military. Extraordinary physical and mental demands are placed upon them, to include superior performance standards, high operational tempos, and the pressure to excel in extreme environments for extended periods of time. In the SOF community, serious injuries are the norm rather than t ...

    STTR Phase II 2021 Department of DefenseSpecial Operations Command
  6. HBI-002 to Treat Parkinson’s Disease

    SBC: Hillhurst Biopharmaceuticals, Inc.            Topic: 107

    PROJECT SUMMARY The goal of the proposed project is to evaluate the potential of HBI-002, a novel oral formulation of carbon monoxide (CO), as a neuroprotective agent in Parkinson’s disease (PD). A growing body of research suggests that low doses of CO - and the heme oxygenase (HO) enzymes that generate endogenous CO - protect against neuronal cell loss in PD, and epidemiologic studies have asso ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  7. Enabling Next Generation Machine Learning for Large Scale Image Analysis

    SBC: RNET TECHNOLOGIES INC            Topic: NIBIB

    Project Summary/Abstract Deep learning has transformed medical image analysis by delivering clinically meaningful results on challenging problems like prostate cancer detection and lung screening. In pathology, industry is making significant invest- ments to develop deep learning tools for diagnostic use in clinical labs. FDA approval of whole-slide digital pathology images (WSIs) for use in prim ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  8. A Smart Assistant for MRI Technologists

    SBC: Biopac Systems, Inc.            Topic: NIBIB

    Abstract Magnetic resonance imaging (MRI) is critically important for pediatric care and the unusable data caused by patient motion has been estimated to cost $1.4B per year in the United States alone. Currently, a radiologist assesses if the images are satisfactory or not, but an MRI technologist does the imaging, and coordination of communication between the two is costly and slow. We propose to ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  9. Protection of donor kidneys with synchronization modulation electric field (SMEF)

    SBC: WR Biotech, LLC            Topic: 400

    The objective of this proposal is to examine a novel technique called improved Synchronization Modulation Electric Field (i-SMEF) in protection of donor kidneys and improvement of transplanted graft functions. We will apply the i-SMEF on donor kidneys during cold storage and evaluate the transplanted graft function following kidney transplantation in mice.We have developed a novel technique, named ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  10. A Novel Therapeutic that Harnesses Microtubules to Promote Cavernous Nerve Regeneration after Radical Prostatectomy

    SBC: MICROCURES INC            Topic: 300

    Radical prostatectomy (RP) is a commonly used treatment option for localized prostate cancer, which carries a high risk for development of erectile dysfunction (ED) because of cavernous nerve (CN) injury. Even newer, nerve-sparing, robotic procedures do not convincingly improve erectile function (EF) outcomes after RP. In addition, ED resulting from RP is often refractory to treatment by orally ad ...

    STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government